These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 15585085)

  • 1. Paucity of antigen-specific IgA responses in sera and external secretions of HIV-type 1-infected individuals.
    Mestecky J; Jackson S; Moldoveanu Z; Nesbit LR; Kulhavy R; Prince SJ; Sabbaj S; Mulligan MJ; Goepfert PA
    AIDS Res Hum Retroviruses; 2004 Sep; 20(9):972-88. PubMed ID: 15585085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the distribution of IgG and IgA antibodies in serum and various mucosal fluids of HIV type 1-infected subjects.
    Raux M; Finkielsztejn L; Salmon-Céron D; Bouchez H; Excler JL; Dulioust E; Grouin JM; Sicard D; Blondeau C
    AIDS Res Hum Retroviruses; 1999 Oct; 15(15):1365-76. PubMed ID: 10515152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predominate HIV1-specific IgG activity in various mucosal compartments of HIV1-infected individuals.
    Lü FX
    Clin Immunol; 2000 Oct; 97(1):59-68. PubMed ID: 10998318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IgG subclass distribution in serum and various mucosal fluids of HIV type 1-infected subjects.
    Raux M; Finkielsztejn L; Salmon-Céron D; Bouchez H; Excler JL; Dulioust E; Grouin JM; Sicard D; Blondeau C
    AIDS Res Hum Retroviruses; 2000 Apr; 16(6):583-94. PubMed ID: 10777149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IgA immunity in HIV type 1-infected chimpanzees. II. Mucosal immunity.
    Black KP; Fultz PN; Girard M; Jackson S
    AIDS Res Hum Retroviruses; 1997 Oct; 13(15):1273-82. PubMed ID: 9339844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibodies to recombinant gp160 in mucosal secretions and sera of persons infected with HIV-1 and seronegative vaccine recipients.
    Funkhouser A; Clements ML; Slome S; Clayman B; Viscidi R
    AIDS Res Hum Retroviruses; 1993 Jul; 9(7):627-32. PubMed ID: 8369168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of cervicovaginal humoral immunity in clinically asymptomatic (CDC A1 and A2 category) patients with HIV-1 and HIV-2 infection.
    Bélec L; Tévi-Bénissan C; Dupré T; Mohamed AS; Prazuck T; Gilquin J; Kanga JM; Pillot J
    J Clin Immunol; 1996 Jan; 16(1):12-20. PubMed ID: 8926281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody to human immunodeficiency virus type 1 (HIV-1) gp160 in mucosal specimens of asymptomatic HIV-1-infected volunteers parenterally immunized with an experimental recombinant HIV-1 IIIB gp160 vaccine. The National Institute of Allergy and Infectious Diseases-sponsored AIDS Vaccine Evaluation Group.
    Lambert JS; Viscidi R; Walker MC; Clayman B; Winget M; Wolff M; Schwartz DH
    Clin Diagn Lab Immunol; 1997 May; 4(3):302-8. PubMed ID: 9144368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-gp160 IgG and IgA antibodies associated with a large increase in total IgG in cervicovaginal secretions from human immunodeficiency virus type 1-infected women.
    Lu XS; Bélec L; Pillot J
    J Infect Dis; 1993 May; 167(5):1189-92. PubMed ID: 8486953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Humoral immune responses to HIV in the mucosal secretions and sera of HIV-infected women.
    Mestecky J; Wei Q; Alexander R; Raska M; Novak J; Moldoveanu Z
    Am J Reprod Immunol; 2014 Jun; 71(6):600-7. PubMed ID: 24494997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mucosal immune responses in four distinct compartments of women infected with human immunodeficiency virus type 1: a comparison by site and correlation with clinical information.
    Artenstein AW; VanCott TC; Sitz KV; Robb ML; Wagner KF; Veit SC; Rogers AF; Garner RP; Byron JW; Burnett PR; Birx DL
    J Infect Dis; 1997 Feb; 175(2):265-71. PubMed ID: 9203646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of HIV-Gag p24-specific antibodies in sera and saliva of HIV-1-infected adults and in sera of infants born to HIV-1-infected mothers.
    Yasuda S; Iwasaki M; Oka S; Naganawa S; Nakasone T; Honda M; Sata T; Kojima A; Matsuda S; Takemori T; Tsunetsugu-Yokota Y
    Microbiol Immunol; 1998; 42(4):305-11. PubMed ID: 9623918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mucosal antibody responses to HIV.
    Moldoveanu Z; Mestecky J
    Methods Mol Biol; 2009; 485():333-45. PubMed ID: 19020835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV-1 neutralizing antibodies in the genital and respiratory tracts of mice intranasally immunized with oligomeric gp160.
    VanCott TC; Kaminski RW; Mascola JR; Kalyanaraman VS; Wassef NM; Alving CR; Ulrich JT; Lowell GH; Birx DL
    J Immunol; 1998 Feb; 160(4):2000-12. PubMed ID: 9469464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IgA immunity in HIV type 1-infected chimpanzees. I. Systemic immunity.
    Black KP; Fultz PN; Girard M; Jackson S
    AIDS Res Hum Retroviruses; 1997 Oct; 13(15):1263-72. PubMed ID: 9339843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum IgA subclasses and molecular forms in HIV infection: selective increases in monomer and apparent restriction of the antibody response to IgA1 antibodies mainly directed at env glycoproteins.
    Kozlowski PA; Jackson S
    AIDS Res Hum Retroviruses; 1992 Oct; 8(10):1773-80. PubMed ID: 1457191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of mucosal antibodies in HIV type 1-infected individuals.
    Wright PF; Kozlowski PA; Rybczyk GK; Goepfert P; Staats HF; VanCott TC; Trabattoni D; Sannella E; Mestecky J
    AIDS Res Hum Retroviruses; 2002 Nov; 18(17):1291-300. PubMed ID: 12487817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV-1 specific IgA detected in vaginal secretions of HIV uninfected women participating in a microbicide trial in Southern Africa are primarily directed toward gp120 and gp140 specificities.
    Seaton KE; Ballweber L; Lan A; Donathan M; Hughes S; Vojtech L; Moody MA; Liao HX; Haynes BF; Galloway CG; Richardson BA; Karim SA; Dezzutti CS; McElrath MJ; Tomaras GD; Hladik F
    PLoS One; 2014; 9(7):e101863. PubMed ID: 25054205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Local synthesis of IgG antibodies to HIV within the female and male genital tracts during asymptomatic and pre-AIDS stages of HIV infection.
    Bélec L; Tévi-Bénissan C; Lu XS; Prazuck T; Pillot J
    AIDS Res Hum Retroviruses; 1995 Jun; 11(6):719-29. PubMed ID: 7576932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and standardization of methods to evaluate the antibody response to an HIV-1 candidate vaccine in secretions and sera of seronegative vaccine recipients.
    Raux M; Finkielsztejn L; Salmon-Céron D; Bouchez H; Excler JL; Dulioust E; Grouin JM; Sicard D; Blondeau C
    J Immunol Methods; 1999 Jan; 222(1-2):111-24. PubMed ID: 10022378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.